Elizaveta Sergeevna Vdoushkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elizaveta Sergeevna Vdoushkina has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Boris Evgenievich Borodulin
Samara State Medical University
17 shared publications - Lyudmila Povalyaeva
Federal State Budgetary Educational Institution of Higher Education “Samara State Medical University” of the Ministry of Healthcare of the Russian Federation
10 shared publications - Zh.P. Vasneva
Samara Diagnostic Center
5 shared publications - A. E. Sukhanova
«Samara State Medical University» of the Ministry of Health of the Russian Federation
4 shared publications - Ekaterina Pavlovna Eremenko
Samara State Medical University
4 shared publications - Kristina Vasilievna Zhilinskaya
Samara State Medical University
4 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (1) , 7-15
Development of a Prognostic Model for the Outcome of Viral Lung Disease Using Machine Learning Algorithms
Background : During periods of increasing respiratory infections, stratifying patient care for virus-associated lung injury is crucial. Objective : To develop a prognostic model for the outcome of viral lung injury using machine learning algorithms. Materials and methods : The study included 295 patients with COVID-associated pneumonia, divided into two groups: 1) deceased (n=78) and 2) survivors (n=217). Data processing was performed using IDE R Studio (Version 4.3.1). The prognostic model was created using potential predictors and machine learning algorithms: multivariate logistic regression, random forest, and stochastic gradient boosting. A 5-fold cross-validation method (KFold) was used. Prediction models for mortality were implemented in Google Colaboratory with Python. Model quality was assessed by metrics such as ROC-AUC and confusion matrix, which provided measures like precision, recall, sensitivity, specificity, and F1-score. Results : The prognostic outcome model was based on mortality predictors, demonstrating a high level of statistical significance between the predicted groups, with significant predictors including the presence of two or more comorbidities, respiratory failure above grade 2, pronounced myalgia and dyspnea, neutrophil-to-lymphocyte ratio >5.1, a critical decrease in eosinophil count accompanied by elevated ESR, glucose, AST, CRP, urea levels, and decreased hemoglobin ( p Conclusion : The mortality risk prediction model developed using machine learning methods, particularly the random forest algorithm (AUC=0.99), demonstrates high accuracy and enables the assessment of mortality risk at hospital admission, guiding management decisions and optimizing treatment strategies.
- 1 March 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (1) , 7-15
Open AccessDevelopment of a Prognostic Model for the Outcome of Viral Lung Disease Using Machine Learning Algorithms
Background : During periods of increasing respiratory infections, stratifying patient care for virus-associated lung injury is crucial. Objective : To develop a prognostic model for the outcome of viral lung injury using machine learning algorithms. Materials and methods : The study included 295 patients with COVID-associated pneumonia, divided into two groups: 1) deceased (n=78) and 2) survivors (n=217). Data processing was performed using IDE R Studio (Version 4.3.1). The prognostic model was created using potential predictors and machine learning algorithms: multivariate logistic regression, random forest, and stochastic gradient boosting. A 5-fold cross-validation method (KFold) was used. Prediction models for mortality were implemented in Google Colaboratory with Python. Model quality was assessed by metrics such as ROC-AUC and confusion matrix, which provided measures like precision, recall, sensitivity, specificity, and F1-score. Results : The prognostic outcome model was based on mortality predictors, demonstrating a high level of statistical significance between the predicted groups, with significant predictors including the presence of two or more comorbidities, respiratory failure above grade 2, pronounced myalgia and dyspnea, neutrophil-to-lymphocyte ratio >5.1, a critical decrease in eosinophil count accompanied by elevated ESR, glucose, AST, CRP, urea levels, and decreased hemoglobin ( p Conclusion : The mortality risk prediction model developed using machine learning methods, particularly the random forest algorithm (AUC=0.99), demonstrates high accuracy and enables the assessment of mortality risk at hospital admission, guiding management decisions and optimizing treatment strategies.
- Open Access
- 8 August 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (4) , 522-529
Tuberculosis under the “mask” of coronavirus pneumonia during the decline of the COVID-19 pandemic
Periods of increased incidence of respiratory viral infections are associated with increased risk of misdiagnosing other diseases with respiratory symptoms, including tuberculosis.The purpose of the study is to analyze the problem of differential diagnosis of pulmonary tuberculosis during the COVID-19 pandemic. Methods. The study was conducted at a city hospital that accepts patients with suspected new coronavirus infection around the clock. Two groups were recruited over 12 months using the continuous sampling method. The first group included 21 patients who were diagnosed with newly developed pulmonary tuberculosis that was initially diagnosed as coronavirus, the second group included 37 patients treated with the diagnosis of a new coronavirus infection. Statistical data processing was performed in MedCalc 19.2.6. Statistical Software.Results. The percentage of men was higher in the group with tuberculosis. No statistically significant differences were found in the medical history. Statistically significant differences between the studied groups were observed in total bilirubin, total protein, C-reactive protein, fibrinogen, ESR, hemoglobin, erythrocytes, leukocytes, platelets, age, the presence of sputum, loss of smell. The logistic regression method was used. Stepwise elimination led to a model that presents the most significant six indicators which can be useful in the differential diagnosis of tuberculosis and coronavirus in patients with a negative PCR test for coronavirus: hemoglobin, fibrinogen, leukocytes, ESR, CRP, and the presence of sputum.Conclusion. Regardless of the current epidemiological situation for seasonal respiratory infections, tuberculosis does not lose its significance as an infectious disease that requires timely and competent differential diagnosis
- 8 August 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (4) , 522-529
Open AccessTuberculosis under the “mask” of coronavirus pneumonia during the decline of the COVID-19 pandemic
Periods of increased incidence of respiratory viral infections are associated with increased risk of misdiagnosing other diseases with respiratory symptoms, including tuberculosis.The purpose of the study is to analyze the problem of differential diagnosis of pulmonary tuberculosis during the COVID-19 pandemic. Methods. The study was conducted at a city hospital that accepts patients with suspected new coronavirus infection around the clock. Two groups were recruited over 12 months using the continuous sampling method. The first group included 21 patients who were diagnosed with newly developed pulmonary tuberculosis that was initially diagnosed as coronavirus, the second group included 37 patients treated with the diagnosis of a new coronavirus infection. Statistical data processing was performed in MedCalc 19.2.6. Statistical Software.Results. The percentage of men was higher in the group with tuberculosis. No statistically significant differences were found in the medical history. Statistically significant differences between the studied groups were observed in total bilirubin, total protein, C-reactive protein, fibrinogen, ESR, hemoglobin, erythrocytes, leukocytes, platelets, age, the presence of sputum, loss of smell. The logistic regression method was used. Stepwise elimination led to a model that presents the most significant six indicators which can be useful in the differential diagnosis of tuberculosis and coronavirus in patients with a negative PCR test for coronavirus: hemoglobin, fibrinogen, leukocytes, ESR, CRP, and the presence of sputum.Conclusion. Regardless of the current epidemiological situation for seasonal respiratory infections, tuberculosis does not lose its significance as an infectious disease that requires timely and competent differential diagnosis
- Open Access
- 13 April 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (1) , 209-217
Effectiveness of artificial intelligence for lung disease screening in a municipal hospital
Background. To organize screening of the population for pulmonary tuberculosis, services based on the use of artificial intelligence technologies (AI services) have been developed and registered.Aim: To evaluate diagnostic metrics and performance of the AI-service as medical decision support system within the framework of routine clinical practice at the scale of a municipal hospital.Material and Methods. The index test was conducted using the software “Automated analysis program for digital chest X-ray/ fluorography images according to TU 62.01.29-001-96876180-2019” produced by LLC “PhthisisBiomed”.Results. The index test of the AI service as a system for supporting medical decision-making showed high values of operational characteristics (sensitivity 96%, specificity 61%), significant savings in the time spent on forming conclusions, and high data transfer rate. The choice of the optimal separation point for screening is reasonably based on the metric of maximizing the predictive value of a negative result (sensitivity maximization). When comparing the diagnostic efficiency of AI-service solutions and physicians, it is shown that the area under the ROC curve of AI-service conclusions (0.91–0.93) is not inferior to that of qualified radiologists (0.78-0.91 according to the literature.Discussion. The use of AI service allows to significantly save the time required to analyze one X-ray image, which is especially important for rapid diagnostics within the framework of screening programs. The use of AI service with high diagnostic efficiency expands the capabilities of radiologists and indicates a transition to a new level of quality of medical care. High speed data transfer allows for better coordination between medical staff and enables faster decision-making for patients.Conclusions. Detection of pathological changes on radiographs of patients using AI-service has high diagnostic efficiency and can be used within the framework of population screening programs for lung diseases.
- 13 April 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (1) , 209-217
Open AccessEffectiveness of artificial intelligence for lung disease screening in a municipal hospital
Background. To organize screening of the population for pulmonary tuberculosis, services based on the use of artificial intelligence technologies (AI services) have been developed and registered.Aim: To evaluate diagnostic metrics and performance of the AI-service as medical decision support system within the framework of routine clinical practice at the scale of a municipal hospital.Material and Methods. The index test was conducted using the software “Automated analysis program for digital chest X-ray/ fluorography images according to TU 62.01.29-001-96876180-2019” produced by LLC “PhthisisBiomed”.Results. The index test of the AI service as a system for supporting medical decision-making showed high values of operational characteristics (sensitivity 96%, specificity 61%), significant savings in the time spent on forming conclusions, and high data transfer rate. The choice of the optimal separation point for screening is reasonably based on the metric of maximizing the predictive value of a negative result (sensitivity maximization). When comparing the diagnostic efficiency of AI-service solutions and physicians, it is shown that the area under the ROC curve of AI-service conclusions (0.91–0.93) is not inferior to that of qualified radiologists (0.78-0.91 according to the literature.Discussion. The use of AI service allows to significantly save the time required to analyze one X-ray image, which is especially important for rapid diagnostics within the framework of screening programs. The use of AI service with high diagnostic efficiency expands the capabilities of radiologists and indicates a transition to a new level of quality of medical care. High speed data transfer allows for better coordination between medical staff and enables faster decision-making for patients.Conclusions. Detection of pathological changes on radiographs of patients using AI-service has high diagnostic efficiency and can be used within the framework of population screening programs for lung diseases.
- Open Access
- 11 July 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (2) , 209-217
A knowledge base generation for creation a medical decision support system for managing the treatment process
The strategy of scientific and technological development of the Russian Federation prioritizes the formation of new approaches to the treatment of tuberculosis, including forms with multidrug resistance. In modern conditions the fulfillment of this task is impossible without the intensive introduction of advanced digital and intelligent technologies, robotic systems and systems using artificial intelligence methods. This approach should start with an important component –the creation of a knowledge base.Aim: To create a knowledge base of drug therapy based on the appropriate ontology, to assemble a prototype of a medical decision support system for managing the treatment of patients with pulmonary tuberculosis.Material and Methods. Current scientific data and recommendations for the treatment of pulmonary tuberculosis in adults were used, according to clinical recommendations approved by the Ministry of Health of the Russian Federation in 2022. The IACPaaS platform is used to implement the intelligent service.Results. A knowledge base has been created to manage the treatment of patients with pulmonary tuberculosis, which allows you to structure knowledge about drug therapy of tuberculosis, define concepts, relationships and axioms describing this process. Each element of the ontology includes a complexly structured block of conditions that allows you to describe in a formal presentation the necessary clinical criteria that determine the conditions for creating an intelligent assistant to a phthisiologist.Conclusion. The generation of the knowledge base will make it possible to switch to personalized medicine through the rational use of anti-tuberculosis drugs, which will reduce the time and improve the effectiveness of tuberculosis treatment.
- 11 July 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (2) , 209-217
Open AccessA knowledge base generation for creation a medical decision support system for managing the treatment process
The strategy of scientific and technological development of the Russian Federation prioritizes the formation of new approaches to the treatment of tuberculosis, including forms with multidrug resistance. In modern conditions the fulfillment of this task is impossible without the intensive introduction of advanced digital and intelligent technologies, robotic systems and systems using artificial intelligence methods. This approach should start with an important component –the creation of a knowledge base.Aim: To create a knowledge base of drug therapy based on the appropriate ontology, to assemble a prototype of a medical decision support system for managing the treatment of patients with pulmonary tuberculosis.Material and Methods. Current scientific data and recommendations for the treatment of pulmonary tuberculosis in adults were used, according to clinical recommendations approved by the Ministry of Health of the Russian Federation in 2022. The IACPaaS platform is used to implement the intelligent service.Results. A knowledge base has been created to manage the treatment of patients with pulmonary tuberculosis, which allows you to structure knowledge about drug therapy of tuberculosis, define concepts, relationships and axioms describing this process. Each element of the ontology includes a complexly structured block of conditions that allows you to describe in a formal presentation the necessary clinical criteria that determine the conditions for creating an intelligent assistant to a phthisiologist.Conclusion. The generation of the knowledge base will make it possible to switch to personalized medicine through the rational use of anti-tuberculosis drugs, which will reduce the time and improve the effectiveness of tuberculosis treatment.
- Open Access
- 25 December 2023
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 101 (6) , 82-88
Wegener's Granulomatosis (Granulomatosis with Polyangiitis). Difficulties in Diagnosis in the Post-COVID Period
The article describes a clinical case of Wegener's granulomatosis, which manifested in the post-COVID period in a young man; also it discusses diagnostic difficulties.
- 25 December 2023
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 101 (6) , 82-88
Open AccessWegener's Granulomatosis (Granulomatosis with Polyangiitis). Difficulties in Diagnosis in the Post-COVID Period
The article describes a clinical case of Wegener's granulomatosis, which manifested in the post-COVID period in a young man; also it discusses diagnostic difficulties.
- Open Access
- 3 October 2023
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (4) , 101-108
Features of peripheral blood cellular immunity parameters in patients with lung damage up to 30 % in COVID-19
Background. The stability of human organism for different kind of infection, including SARS-CoV-2 is significantly defined by the immune system. The mechanisms of the cellular immunity to the SARS-CoV-2 are not exactly defined and are under study. The aim. To study the features of cell immunity parameters in patients with lung damage up to 30 % in COVID-19. Material and methods. 73 people were examined during the 2020–2021 pandemic. The study group consisted of 31 patients with lung damage up to 30 % with COVID-19, the comparison group consisted of 42 people not infected with SARS-CoV-2. A complete clinical blood count was carried out using a Medonic M20 hematological analyzer (Boule Medical, Sweden), the level of lymphocyte subpopulations was determined using a FACS Calibur cytometer (BD, USA) and FITC- and phycoerythrin-labeled monoclonal antibodies (Sorbent, Russia). Differences were considered statistically significant at p < 0.05. Results. Patients with COVID-19 with lung damage according to computed tomography (CT) ≤ 30 % before the treatment had a restructuring in the ratio of lymphocyte subpopulations in 67.7 % of cases. Lymphopenia (< 1.1 × 109 cells/l) was detected in 34.4 % of patients: a decrease in the absolute count of CD3+ lymphocytes by 30.8 %, CD3+CD4+ – by 35 %, CD3+CD8+ – by 6.7 % (p < 0.05), CD16+CD56+ natural killer (NK) cells – by 29.4 % (p = 0.009). The level of CD95+ lymphocytes in COVID-19 is 3.2 times higher than in healthy individuals. Elevated levels of HLA-DR+- (> 20 %) and CD3+ HLADR+ lymphocytes (> 6 %) are recorded in 60 % and 86.7 % of patients, respectively. Elevated levels of CD19+ B lymphocytes (> 17 %) in COVID-19 are 2.6 times more common than in healthy individuals. Correlation dependences of the count of NK cells with a wide range of T lymphocyte subpopulations were revealed. Conclusion. Cellular immunity indicators in COVID-19 have a number of features that can serve as predictors of the progression of the severity of the disease.
- 3 October 2023
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (4) , 101-108
Open AccessFeatures of peripheral blood cellular immunity parameters in patients with lung damage up to 30 % in COVID-19
Background. The stability of human organism for different kind of infection, including SARS-CoV-2 is significantly defined by the immune system. The mechanisms of the cellular immunity to the SARS-CoV-2 are not exactly defined and are under study. The aim. To study the features of cell immunity parameters in patients with lung damage up to 30 % in COVID-19. Material and methods. 73 people were examined during the 2020–2021 pandemic. The study group consisted of 31 patients with lung damage up to 30 % with COVID-19, the comparison group consisted of 42 people not infected with SARS-CoV-2. A complete clinical blood count was carried out using a Medonic M20 hematological analyzer (Boule Medical, Sweden), the level of lymphocyte subpopulations was determined using a FACS Calibur cytometer (BD, USA) and FITC- and phycoerythrin-labeled monoclonal antibodies (Sorbent, Russia). Differences were considered statistically significant at p < 0.05. Results. Patients with COVID-19 with lung damage according to computed tomography (CT) ≤ 30 % before the treatment had a restructuring in the ratio of lymphocyte subpopulations in 67.7 % of cases. Lymphopenia (< 1.1 × 109 cells/l) was detected in 34.4 % of patients: a decrease in the absolute count of CD3+ lymphocytes by 30.8 %, CD3+CD4+ – by 35 %, CD3+CD8+ – by 6.7 % (p < 0.05), CD16+CD56+ natural killer (NK) cells – by 29.4 % (p = 0.009). The level of CD95+ lymphocytes in COVID-19 is 3.2 times higher than in healthy individuals. Elevated levels of HLA-DR+- (> 20 %) and CD3+ HLADR+ lymphocytes (> 6 %) are recorded in 60 % and 86.7 % of patients, respectively. Elevated levels of CD19+ B lymphocytes (> 17 %) in COVID-19 are 2.6 times more common than in healthy individuals. Correlation dependences of the count of NK cells with a wide range of T lymphocyte subpopulations were revealed. Conclusion. Cellular immunity indicators in COVID-19 have a number of features that can serve as predictors of the progression of the severity of the disease.
- 16 August 2022
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 32 (4) , 576-584
Test with recombinant tuberculosis allergen (Diaskintest®) in the diagnosis of pulmonary tuberculosis in pulmonological practice
Differential diagnosis of pulmonary tuberculosis and community-acquired pneumonia remains an urgent problem in primary health care despite the improvement of radiological and laboratory diagnostic methods.The aimof study was to evaluate the possibility of using a skin test with recombinant tuberculosis allergen (Diaskintest®, Generium, Russia) for the differential diagnosis of pulmonary tuberculosis and pneumonia.Methods.119 cases of pulmonary tuberculosis first detected in the pulmonology department during differential diagnosis were analyzed. The diagnosis was verified by a liquid media culture in the BACTEC MGIT 960 system (BD, USA). All patients with suspected tuberculosis had a skin test with recombinant tuberculosis allergen upon admission. Statistical analysis was carried out using the statistical software package IBM SPSS Statistics 22.0. The differences were considered statistically significant atp< 0.05.Results.Most patients were of working age and had aggravating social risk factors 49 (41.2%), HIV-infection 75 (63.0%), drug addiction 44 (36.9%), or viral hepatitis C 33 (24.2%). As for the clinical forms, infiltrative and disseminated tuberculosis prevailed. Evaluation of the results of the «fast» methods of the diagnostic minimum showed that a positive result of the test with Diaskintest®was almost three times more likely than the positive result of bacterioscopy of a sputum smear with Ziehl–Neelsen staining.Mycobacterium tuberculosisDNA was detected in sputum using the GeneXpert MTB/RIF cartridge technology in 92.6% patients with a positive result of Diaskintest®skin test and a negative sputum bacterioscopy analysis.Conclusion.Is advisable to use Diaskintest®skin test in patients of a pulmonological hospital in the early stages and confirm the positive result with GeneXpert MTB/RIF to reduce the time for diagnosing tuberculosis and the patient’s bed-days in a non-specialized medical institution.
- 16 August 2022
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 32 (4) , 576-584
Test with recombinant tuberculosis allergen (Diaskintest®) in the diagnosis of pulmonary tuberculosis in pulmonological practice
Differential diagnosis of pulmonary tuberculosis and community-acquired pneumonia remains an urgent problem in primary health care despite the improvement of radiological and laboratory diagnostic methods.The aimof study was to evaluate the possibility of using a skin test with recombinant tuberculosis allergen (Diaskintest®, Generium, Russia) for the differential diagnosis of pulmonary tuberculosis and pneumonia.Methods.119 cases of pulmonary tuberculosis first detected in the pulmonology department during differential diagnosis were analyzed. The diagnosis was verified by a liquid media culture in the BACTEC MGIT 960 system (BD, USA). All patients with suspected tuberculosis had a skin test with recombinant tuberculosis allergen upon admission. Statistical analysis was carried out using the statistical software package IBM SPSS Statistics 22.0. The differences were considered statistically significant atp< 0.05.Results.Most patients were of working age and had aggravating social risk factors 49 (41.2%), HIV-infection 75 (63.0%), drug addiction 44 (36.9%), or viral hepatitis C 33 (24.2%). As for the clinical forms, infiltrative and disseminated tuberculosis prevailed. Evaluation of the results of the «fast» methods of the diagnostic minimum showed that a positive result of the test with Diaskintest®was almost three times more likely than the positive result of bacterioscopy of a sputum smear with Ziehl–Neelsen staining.Mycobacterium tuberculosisDNA was detected in sputum using the GeneXpert MTB/RIF cartridge technology in 92.6% patients with a positive result of Diaskintest®skin test and a negative sputum bacterioscopy analysis.Conclusion.Is advisable to use Diaskintest®skin test in patients of a pulmonological hospital in the early stages and confirm the positive result with GeneXpert MTB/RIF to reduce the time for diagnosing tuberculosis and the patient’s bed-days in a non-specialized medical institution.
- 1 January 2022
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 68-70
Peripheral blood cellular immunity parameters in COVID-19
В статье приведены результаты исследования показателей клеточного иммунитета у пациентов с COVID-19, поступивших на стационарное лечение в 2020 г. с поражением легочной ткани до 30%. При инфицировании SARS-CoV-2 на фоне выраженной лимфопении и нейтрофилии выявлены разнонаправленные изменения ряда показателей клеточного иммунитета, степень выраженности и динамика которых может определяться исходным типом реагирования иммунной...
- 1 January 2022
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 68-70
Peripheral blood cellular immunity parameters in COVID-19
В статье приведены результаты исследования показателей клеточного иммунитета у пациентов с COVID-19, поступивших на стационарное лечение в 2020 г. с поражением легочной ткани до 30%. При инфицировании SARS-CoV-2 на фоне выраженной лимфопении и нейтрофилии выявлены разнонаправленные изменения ряда показателей клеточного иммунитета, степень выраженности и динамика которых может определяться исходным типом реагирования иммунной...
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (3)
Features of the COVID-19 in lung tissue damage admitted to hospital
Особенности COVID-19 при поражении легочной ткани у поступающих на стационарное лечение
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (3)
Features of the COVID-19 in lung tissue damage admitted to hospital
Особенности COVID-19 при поражении легочной ткани у поступающих на стационарное лечение
- 1 January 2022
- Published by Russian Vrach, Publishing House Ltd. in Meditsinskaya Sestra
- Vol. 24 (7) , 11-16
Economic analysis assortment of medications and the volume of their consumption in Older patients diagnosed with COVID-19 using the example of Antibiotic use
Цель исследования. Проведен анализ ассортимента лекарственных препаратов и объема их потребления у пациентов старших возрастных групп с диагнозом COVID-19. Материалы и методы. Проведен анализ 218 историй болезней пациентов с коронавирусной инфекцией, которые проходили лечение в ковид-госпитале, были успешно пролечены и впоследствии выписаны. Сформированы группы госпитализированных пациентов в возрасте старше 65 лет (группа исследования) и младше 65 лет (группа сравнения). Изучены возрастные, анамнестические, клинические, лабораторные данные с использованием стандартизированных баз данных пациентов с COVID-19 (Свидетельства государственной регистрации № 2020622119 и № 2021621990). Изучены основные препараты, используемые для лечения пациентов, объема их потребления. Для проведения анализа были использованы ретроспективный, логический, графический, аналитический методы исследования. Статическая обработка полученных данных проводилась с использованием прикладного программного пакета Statistica 10.0. Результаты и их обсуждение. Лидирующие позиции по объему денежных средств занимают антибактериальные препараты и иммунодепрессивные препараты для снижения избыточного иммунного воспаления. Схемы и стоимость антибактериальной терапии существенно не различались, у пациентов старше 65 лет преобладало назначение имипенема, в ОРиИТ отмечено назначение линезолида, ванкомицина и аквапенема. Выводы. Течение COVID-19 с поражением легких, госпитализированных на стационарное лечение, у лиц старших возрастных групп и лиц трудоспособного возраста было примерно одинаковым, но среди сопутствующих заболеваний у лиц старшей возрастной группы преобладали артериальная гипертензия и сахарный диабет. Практика лечения новой коронавирусной инфекции вносила свои коррективы в совершенствование временных методических...
- 1 January 2022
- Published by Russian Vrach, Publishing House Ltd. in Meditsinskaya Sestra
- Vol. 24 (7) , 11-16
Economic analysis assortment of medications and the volume of their consumption in Older patients diagnosed with COVID-19 using the example of Antibiotic use
Цель исследования. Проведен анализ ассортимента лекарственных препаратов и объема их потребления у пациентов старших возрастных групп с диагнозом COVID-19. Материалы и методы. Проведен анализ 218 историй болезней пациентов с коронавирусной инфекцией, которые проходили лечение в ковид-госпитале, были успешно пролечены и впоследствии выписаны. Сформированы группы госпитализированных пациентов в возрасте старше 65 лет (группа исследования) и младше 65 лет (группа сравнения). Изучены возрастные, анамнестические, клинические, лабораторные данные с использованием стандартизированных баз данных пациентов с COVID-19 (Свидетельства государственной регистрации № 2020622119 и № 2021621990). Изучены основные препараты, используемые для лечения пациентов, объема их потребления. Для проведения анализа были использованы ретроспективный, логический, графический, аналитический методы исследования. Статическая обработка полученных данных проводилась с использованием прикладного программного пакета Statistica 10.0. Результаты и их обсуждение. Лидирующие позиции по объему денежных средств занимают антибактериальные препараты и иммунодепрессивные препараты для снижения избыточного иммунного воспаления. Схемы и стоимость антибактериальной терапии существенно не различались, у пациентов старше 65 лет преобладало назначение имипенема, в ОРиИТ отмечено назначение линезолида, ванкомицина и аквапенема. Выводы. Течение COVID-19 с поражением легких, госпитализированных на стационарное лечение, у лиц старших возрастных групп и лиц трудоспособного возраста было примерно одинаковым, но среди сопутствующих заболеваний у лиц старшей возрастной группы преобладали артериальная гипертензия и сахарный диабет. Практика лечения новой коронавирусной инфекции вносила свои коррективы в совершенствование временных методических...